James J Loughlin - Net Worth and Insider Trading
James J Loughlin Net Worth
The estimated net worth of James J Loughlin is at least $4 Million dollars as of 2024-04-19. James J Loughlin is the Director of Celgene Corp and owns about 40,436 shares of Celgene Corp (CELG) stock worth over $4 Million. James J Loughlin is also the Director of PDS Biotechnology Corp and owns about 1,281 shares of PDS Biotechnology Corp (PDSB) stock worth over $3,388. Details can be seen in James J Loughlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James J Loughlin has not made any transactions after 2019-02-07 and currently still holds the listed stock(s).
Transaction Summary of James J Loughlin
James J Loughlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James J Loughlin owns 2 companies in total, including PDS Biotechnology Corp (PDSB) , and InspireMD Inc (NSPR) .
Click here to see the complete history of James J Loughlin’s form 4 insider trades.
Insider Ownership Summary of James J Loughlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PDSB | PDS Biotechnology Corp | 2017-03-06 | director |
| NSPR | InspireMD Inc | 2012-09-21 | director |
James J Loughlin Latest Holdings Summary
James J Loughlin currently owns a total of 2 stocks. Among these stocks, James J Loughlin owns 40,436 shares of Celgene Corp (CELG) as of February 7, 2019, with a value of $4 Million and a weighting of 99.92%. James J Loughlin also owns 1,281 shares of PDS Biotechnology Corp (PDSB) as of March 6, 2017, with a value of $3,388 and a weighting of 0.08%.
Latest Holdings of James J Loughlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CELG | Celgene Corp | 2019-02-07 | 40,436 | 108.24 | 4,376,793 |
| PDSB | PDS Biotechnology Corp | 2017-03-06 | 1,281 | 2.65 | 3,388 |
Holding Weightings of James J Loughlin
James J Loughlin Form 4 Trading Tracker
According to the SEC Form 4 filings, James J Loughlin has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 23,466 shares on February 7, 2019, which brought James J Loughlin around $2 Million.
According to the SEC Form 4 filings, James J Loughlin has made a total of 0 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years. The most-recent trade in PDS Biotechnology Corp is the acquisition of 150 shares on March 6, 2017, which cost James J Loughlin around $27,720.
Insider Trading History of James J Loughlin
- 1
James J Loughlin Trading Performance
GuruFocus tracks the stock performance after each of James J Loughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James J Loughlin is 17.99%. GuruFocus also compares James J Loughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by James J Loughlin within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James J Loughlin's insider trading performs compared to the benchmark.
Performance of James J Loughlin
Average Return
39.41%
Outperforming Transactions
80%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | 17.99 | 14.25 | 39.41 | 8.58 | -24.57 |
| Relative Return to S&P 500(%) | 3.74 | 13.14 | 6.89 | 22.75 | -7.61 | -37.23 |
James J Loughlin Ownership Network
Ownership Network List of James J Loughlin
Ownership Network Relation of James J Loughlin
James J Loughlin Owned Company Details
What does PDS Biotechnology Corp do?
Who are the key executives at PDS Biotechnology Corp?
James J Loughlin is the director of PDS Biotechnology Corp. Other key executives at PDS Biotechnology Corp include Senior VP & General Counsel Spencer D. Brown , Chief Financial Officer Matthew C Hill , and director & 10 percent owner Delyle W Bloomquist .
PDS Biotechnology Corp (PDSB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PDS Biotechnology Corp (PDSB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDS Biotechnology Corp (PDSB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PDS Biotechnology Corp (PDSB)'s detailed insider trading history can be found in Insider Trading Tracker table.
PDS Biotechnology Corp Insider Transactions
James J Loughlin Mailing Address
Above is the net worth, insider trading, and ownership report for James J Loughlin. You might contact James J Loughlin via mailing address: Dorsey & Whitney Llp, 250 Park Ave, New York Ny 10177.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
